Evaluation of Resection Techniques for Pancreatic Tumors
Study Details
Study Description
Brief Summary
The objective of this study is to compare open and minimally invasive pancreatic and liver resection techniques and analyze the different outcome variables from the clinical standpoint.
The plan is to investigate patient survival, length of stay, complication rates, operative time, transfusion rate, 30 and 90-day readmission rate, and hospital charges.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
The plan is to conduct a retrospective chart review of patients who have undergone pancreatic and liver resection by using Meditech and Epic. A non-identified database will be created after retrospectively reviewing each patient case involving pancreatic or liver resection at MDMC. The study period will start in January 2006 until October 31, 2017. Variables will include demographics, clinical disease diagnoses, and operative parameters as well as indirect charges from the hospitalizations.
Study Design
Outcome Measures
Primary Outcome Measures
- Patient Survival [through study completion, an average of 1 year]
It will be calculated in days.Minimally invasive techniques are being adopted for complex pancreatic and liver surgery and there is a need to understand if these techniques are advantageous to the patient, if the cost is justified and if the risks are acceptable when compared to the gold standard open surgery.
- Length of stay [Up to 1 year]
It will be calculated in days. The days stayed in hospital post-procedure.
- Complication rates [through study completion, an average of 1 year]
Patient may visit physician or hospital for any symptoms or may need hospitalizations.
- Operative time [up to 10 hours]
The time required for the procedure.
- Transfusion rate [through study completion, an average of 1 year]
If any post-procedure transfusion required, will be recorded.
- 30 and 90 day readmission rate [through study completion, an average of 1 year]
After the procedure any hospital admissions up to 30 days will be recorded.
- Hospital charges [through study completion, an average of 1 year]
The hospital charges for the procedure will be recorded.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
• Patients that have undergone pancreatic or liver resection surgeries from January 2006 until October 31, 2017 at Methodist Dallas Medical Center (MDMC)
-
Patients 18 years old or older
Exclusion Criteria:
-
• Patients that have not undergone pancreatic resection surgeries
-
Patients under 18 years of age
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Methodist Health System
Investigators
- Principal Investigator: Alejandro Mejia, M.D., The Liver Institute, Methodist Dallas Medical Center
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 028.HPB.2016.D